Salarius Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.45-$4.50 |
Market Cap | $1.4M |
Shares Short | 112,934 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$15.8M |
Diluted EPS | -$5.79 |
News
See moreYahoo Finance • 13 days ago
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
Yahoo Finance • last month
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Yahoo Finance • last year
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
About
CEO | Mr. David J. Arthur M.B.A. |
CFO | Mr. Mark J. Rosenblum CPA |
Address | 2450 Holcombe Blvd., Houston, TX, United States, 77021 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
